Laurent Marsollier Selected Research

Buruli Ulcer

12/2021	Ketogenic Diet Impairment of Mycobacterium ulcerans Growth and Toxin Production and Enhancement of Host Response to Infection in an Experimental Mouse Model.
1/2020	Vaccine-Specific Immune Responses against Mycobacterium ulcerans Infection in a Low-Dose Murine Challenge Model.
1/2020	High antibody titres induced by protein subunit vaccines using Mycobacterium ulcerans antigens Hsp18 and MUL_3720 with a TLR-2 agonist fail to protect against Buruli ulcer in mice.
1/2019	Could Mycolactone Inspire New Potent Analgesics? Perspectives and Pitfalls.
1/2018	The potent effect of mycolactone on lipid membranes.
1/2017	An Optimized Method for Extracting Bacterial RNA from Mouse Skin Tissue Colonized by Mycobacterium ulcerans.
1/2017	A Bacterial Toxin with Analgesic Properties: Hyperpolarization of DRG Neurons by Mycolactone.
4/2015	Development of a dry-reagent-based qPCR to facilitate the diagnosis of Mycobacterium ulcerans infection in endemic countries.
6/2014	Mycobacterial toxin induces analgesia in buruli ulcer by targeting the angiotensin pathways.
11/2010	Serological evaluation of Mycobacterium ulcerans antigens identified by comparative genomics.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Laurent Marsollier Research Topics

Disease

16	Buruli Ulcer 12/2021 - 04/2003
7	Infections 12/2021 - 08/2005
2	Skin Ulcer 12/2021 - 01/2019
2	Communicable Diseases (Infectious Diseases) 12/2021 - 01/2019
2	Pain (Aches) 01/2019 - 01/2017
2	Hypesthesia (Numbness) 01/2019 - 06/2014
2	Ulcer 01/2011 - 02/2007
2	Tuberculosis (Tuberculoses) 10/2009 - 09/2006
1	Neglected Diseases 01/2020
1	Nerve Degeneration 01/2019
1	Inflammation (Inflammations) 01/2018
1	Spontaneous Remission 03/2016
1	Wounds and Injuries (Trauma) 11/2011
1	Leprosy (Hansen's Disease) 04/2003

Drug/Important Bio-Agent (IBA)

10	mycolactoneIBA 12/2021 - 08/2005
5	PolyketidesIBA 01/2019 - 08/2008
4	mycolactone AIBA 01/2019 - 08/2008
3	Virulence Factors (Pathogenicity Factors)IBA 12/2021 - 11/2009
3	Proteins (Proteins, Gene)FDA Link 01/2020 - 09/2006
2	RNA (Ribonucleic Acid)IBA 12/2021 - 01/2017
2	VaccinesIBA 01/2020 - 07/2006
2	Analgesics (Analgesic Drugs)IBA 01/2019 - 01/2017
2	Rifampin (Rifampicin)FDA LinkGeneric 01/2011 - 04/2003
2	Immunoglobulin G (IgG)IBA 11/2010 - 02/2007
1	Protein Subunit VaccinesIBA 01/2020
1	AntigensIBA 01/2020
1	Interferon-gamma (Interferon, gamma)IBA 01/2020
1	Interleukin-2 (IL2)IBA 01/2020
1	Angiotensin Receptors (Angiotensin II Receptor)IBA 01/2019
1	LactonesIBA 01/2019
1	ExotoxinsIBA 01/2019
1	EndotoxinsIBA 01/2018
1	LipidsIBA 01/2018
1	Indicators and Reagents (Reagents)IBA 04/2015
1	AngiotensinsIBA 06/2014
1	Soaps (Soap)IBA 11/2011
1	Clarithromycin (Biaxin)FDA LinkGeneric 01/2011
1	Polyketide SynthasesIBA 11/2010
1	PropionatesIBA 11/2010
1	Secretory Immunoglobulin A (SIgA)IBA 11/2009
1	lipoarabinomannan (LAM)IBA 10/2009
1	arabinogalactanIBA 10/2009
1	Pharmaceutical PreparationsIBA 10/2009
1	Racemases and Epimerases (Epimerases and Racemases)IBA 10/2009
1	Arabinose (L-Arabinose)IBA 10/2009
1	Histidine (L-Histidine)FDA Link 09/2006
1	Protein Sorting Signals (Signal Peptide)IBA 09/2006
1	Arginine (L-Arginine)FDA Link 09/2006
1	beta Lactam AntibioticsIBA 09/2006
1	DNA VaccinesIBA 07/2006
1	Chemokine CXCL2IBA 08/2005
1	MacrolidesIBA 08/2005
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 08/2005

Therapy/Procedure

2	Analgesia 01/2019 - 06/2014
1	Ketogenic Diet 12/2021
1	Subcutaneous Injections 01/2019
1	Drug Therapy (Chemotherapy) 01/2011